Spanish scientists have achieved a major breakthrough by eliminating pancreatic cancer in mice using a triple‑drug therapy. According to the Spanish National Cancer Research Centre, a team led by Dr. Mariano Barbacid has successfully eliminated pancreatic tumors in mice using a combination of three drugs. The therapy targets the KRAS oncogene pathway, which is responsible for most cases of pancreatic cancer and has long been considered impossible to treat directly. This achievement is being described as one of the most important advances in cancer research in recent years.
The researchers emphasize that while the results are groundbreaking, they are still at the preclinical stage. The therapy has not yet been tested in humans, and clinical trials will be necessary to determine whether the treatment is safe and effective for patients. While it is not yet a cure for humans, the research provides hope that future therapies could dramatically improve survival rates for pancreatic cancer patients.
The researchers emphasize that while the results are groundbreaking, they are still at the preclinical stage. The therapy has not yet been tested in humans, and clinical trials will be necessary to determine whether the treatment is safe and effective for patients. While it is not yet a cure for humans, the research provides hope that future therapies could dramatically improve survival rates for pancreatic cancer patients.